Lumenis Highlights ActiveFX™ and Scientific Sessions Supporting its Technology at the 65th Annual American Academy of Dermatology Meeting

Lumenis® Ltd., a global developer, manufacturer and seller of laser, light-based and radiofrequency devices for medical, aesthetic, ophthalmic, dental and veterinary applications, announced today the company will highlight its exciting ActiveFX procedure at the upcoming annual meeting of the American Academy of Dermatology in Washington, DC (USA). ActiveFX™ and several other key innovations by Lumenis, such as the Aluma™ Skin Renewal System and Lumenis One™ with 4th generation IPL® (Intense Pulsed Light) technology, will be discussed in scientific sessions by leading dermatologists throughout the annual meeting.

In a single treatment, the ActiveFX procedure provides remarkable results with minimal downtime using the UltraPulse® Encore™ CO2 laser.  ActiveFX treats common complaints prevalent in the aging yet active ‘baby boomer’ population such as fine lines, wrinkles, skin laxity, freckles and ’age spots’, as well as other signs of photo-aging and sun damage.

“ActiveFX fractional CO2 resurfacing represents yet another exciting first for Lumenis,” commented Harel Beit-On, Chairman of the Board at Lumenis. “While we have over 10 years of proven clinical efficacy with our UltraPulse technology, ActiveFX is the first fractional CO2 resurfacing procedure offering both the minimal downtime associated with fractional procedures and the ‘gold standard’ results of our CO2 laser.  Physicians and patients around the world have responded favorably to this procedure, which we believe has broad appeal and demonstrates impressive efficacy.”

“What we are seeing in my practice is that increasingly patients are willing to tolerate a short downtime to achieve more dramatic results.  ActiveFX provides significant improvement in texture and reduction in dyschromia with a low risk of adverse effects and minimal downtime.  My patients have been very satisfied with the ActiveFX procedure,” reports David Goldberg, MD, of Westwood, NJ (USA).

Scientific Sessions at the AAD Supporting Lumenis Innovations

Several thought-leading physicians are scheduled throughout the AAD meeting to discuss Lumenis systems and platforms, including: ActiveFX, Aluma Radiofrequency Skin Renewal and IPL Skin Treatments with the Lumenis One System. Highlights include:

• SYM317 - Mitchel Goldman, MD: Minimally Invasive Facial Rejuvenation; Saturday, February 3, 7:00 AM
• SYM317 – Jaggi Rao, MD: Vacuum-Assisted Radiofrequency; Saturday, February 3, 8:15 AM
• SYM317 - Robert Weiss, MD: Microablative, Fractional and Macroablative Resurfacing; Saturday, February 3, 8:30 AM
• FOC656 - Melanie Grossman, MD: New and Emerging Non-Invasive Cosmetic Laser Treatments and Devices; Monday, February 5, 7:15-8:45 AM
• CRS116 - Mitchel Goldman, MD: Combining and Timing Botulinum Toxin with Adjunctive Aesthetic Facial Procedures; Monday, February 5, 11:05 AM
• P3115 - David Goldberg, MD: Reduced Down-time Associated with Novel Fractional UltraPulse CO2 Treatment (Active FX) as Compared to Traditional Resurfacing
• P3117 - Michael Gold, MD: Bipolar Radiofrequency with Vacuum Apparatus in the Treatment of Acne Scars
• P3119 - Michael Gold, MD: Vacuum-Assisted Bipolar Radiofrequency Therapy

For a complete list of speaker presentations, visit Lumenis in booth #2225 at the American Academy of Dermatology meeting in The Washington Convention Center, February 3-5, 2007.

About ActiveFX

The ActiveFX procedure works by applying CO2 laser energy in a very narrow, scanned beam. This results in the creation of very tiny columns of thermal damage that penetrate deep down to the dermis and stimulate the growth of new collagen. The energy is applied in a "fractional" way – that is, the tiny columns of thermal damage are spaced so that tissue between each column is spared – resulting in more rapid healing, typically only 4 -7 days. ActiveFX differs from other aesthetic procedures employing fractional approaches because it uses CO2 laser energy, which is considered to be the optimal treatment technology. For more information about ActiveFX, log onto: http://www.activefxmaxfx.com

About Lumenis

Lumenis is a global developer, manufacturer and seller of laser, light- and radiofrequency-based devices for medical, aesthetic, ophthalmic, dental and veterinary applications. The Company offers a wide range of products along with extensive product support systems including training, education and service. Lumenis invests heavily in research and development to maintain and enhance its leading industry position. The Company holds numerous patents worldwide on its technologies. For more information about Lumenis and its products, log onto: http://www.lumenis.com

For further information:

Investors:

Lauri Hanover
1-866-232-6803
972-4-959-9122